These are the top 15 prostate cancer specialists in the United States: A National Research Overview
When patients receive a complex urologic oncology diagnosis, identifying leading clinical expertise becomes an immediate priority for treatment planning. These are the top 15 prostate cancer specialists in the United States who have built established reputations through verified clinical volume, peer-reviewed publications, and extensive patient-rated expertise. Selecting an appropriate physician involves assessing their board certifications, specific procedural experience, and their alignment with leading research institutions across the country.
Rigorous Standards for Evaluating Prostate Cancer Expertise
Evaluating clinical excellence in prostate oncology requires analyzing objective benchmarks. Peer reviews, such as those compiled by Statista and Newsweek, measure specialist quality based on four pillars: historical Medicare claims data, peer-recommendation surveys, board certifications, and quality-of-care ratings 1. Board certification from the American Board of Urology or the American Board of Internal Medicine is the baseline credential ensuring a practitioner maintains updated clinical competencies in complex oncological cases 1.
Furthermore, the American Urological Association advises that selecting a prostate cancer specialist is most effective when aligning clinical subspecialties with the disease stage 2. Because prostate care often requires a combination of surgery, radiation, and systemic therapy, elite practitioners operate within multidisciplinary teams. These teams integrate urologists, radiation oncologists, and pathologists to ensure that treatment decisions align with evidence-based frameworks, such as the National Comprehensive Cancer Network guidelines, optimizing patient safety 2.
Leading Urological Surgeons Specialized in Prostate Care
Among the highly rated urologists in the United States, several practitioners stand out due to high procedural volumes and exceptional peer ratings. Dr. Frank Andersen, based in Laguna Beach, California, has documented over 13,900 procedures during his nineteen years of practice, maintaining a five-star patient rating 3. Similarly, Dr. Jonathan Bergman in Los Angeles, California, possesses eighteen years of experience and has published over 145 scientific papers, showcasing a strong academic footprint alongside a caseload of over 6,700 procedures 3.
In Houston, Texas, Dr. Ahmad Bani Hani provides specialized urologic services with twenty years of practice and 9,400 completed procedures 3. Other urology specialists include Dr. Sohrab Naushad Ali, practicing in Orange, California, and Dr. Virinder Bhardwaj, based in Porterville, California, who has logged twenty years of clinical experience and 4,900 procedures 3. These specialists focus primarily on localized disease, utilizing robotic surgery and advanced diagnostic mapping to achieve optimal cancer clearance while preserving delicate nerve pathways.
Distinguished Medical Oncologists in Advanced Prostate Therapy
When prostate cancer progresses beyond localized boundaries, medical oncologists assume primary responsibility for managing systemic treatments, including hormone therapies and immunotherapies. Dr. Janai Carr-Ascher, practicing in Sacramento, California, holds thirteen years of specialized experience in internal medicine and medical oncology, managing over 9,700 patient procedures 3. In Kingsport, Tennessee, Dr. Nimesh Adhikari has established a robust oncology presence over nine years of practice, compiling 118 academic publications and conducting over 8,700 procedures 3.
Further south, Dr. Meghana Bhandari operates in Sugar Land, Texas, with nineteen years of experience and over 12,700 procedural cases managed 3. In Clearwater, Florida, Dr. Gregoire Bergier brings twenty years of experience with 41 scientific publications, while Dr. Arash Alizadeh represents academic medicine at Stanford, California, with twenty years of clinical dedication and five patents 3. These oncologists focus on halting disease progression using precise pharmaceutical interventions targeted to the molecular profile of the tumor.

Academic Pioneers and Regional Urologic Leaders
Clinical registries highlight several prominent regional specialists who lead academic departments or high-capacity clinics. Dr. Jodi Antonelli in Dallas, Texas, has managed over 13,700 procedures over her eighteen-year career, securing a strong reputation for managing complex urological obstructions 3. In Delray Beach, Florida, Dr. Nathalie Barnes offers twenty-one years of clinical experience with over 8,500 procedures, while Dr. James Abbruzzese in Houston, Texas, and Dr. Gerald Edelman in Killeen, Texas, provide essential oncological support to the southern region, both possessing over twenty years of verified practice histories 3.
Representing academic medicine, Dr. Martin G. Sanda, MD, serves as the Louis McDonald Orr Distinguished Professor of Urology at the Emory University School of Medicine and director of the Prostate Cancer Program at the Winship Cancer Institute 4. Practicing since 1995, Dr. Sanda is an internationally recognized robotic prostate surgeon and principal investigator for multiple National Cancer Institute-funded multi-center studies focused on advanced biomarkers 4.
The Role of NCI-Designated Centers and High-Volume Hospitals
While selecting an individual specialist is crucial, the institutional framework supporting the practitioner significantly influences patient outcomes. National rankings highlight premier specialized care hospitals such as the MD Anderson Cancer Center in Houston, the Mayo Clinic in Rochester, and the Memorial Sloan Kettering Cancer Center in New York City 5. These centers are designated as Comprehensive Cancer Centers by the National Cancer Institute, maintaining the highest transdisciplinary standards for scientific leadership 5.
According to clinical data compiled by the Definitive Healthcare Atlas, hospital systems with massive diagnosis and surgical volumes are associated with lower complication rates 6. The Cleveland Clinic Main Campus leads the nation by managing approximately 4.2 percent of all prostate cancer diagnoses in the United States, followed by the Moffitt Cancer Center in Florida and Stanford Hospital in California 6. Patients seeking treatment at these high-volume hubs benefit from state-of-the-art technologies, such as magnetic resonance imaging fusion biopsies, administered by dedicated clinical teams.
Navigating Risks, Active Surveillance, and Treatment Friction
A balanced approach to prostate cancer care requires recognizing that active intervention is not always the safest or most necessary route. Localized, low-grade prostate cancer exhibits a five-year relative survival rate exceeding 99 percent, meaning many men will not succumb to the disease 7. Consequently, specialists frequently recommend active surveillance for early-stage cases. To avoid unnecessary biopsies or premature surgeries, clinicians utilize molecular biomarker tests, such as the IsoPSA test, to monitor risk levels and identify disease progression 8.
For patients facing advanced or metastatic prostate cancer, navigating eligibility criteria for cutting-edge treatments like Pluvicto, a targeted radioligand therapy, represents a significant hurdle 9. Accessing these specialized therapies requires precise imaging scans, strict adherence to diagnostic thresholds, and coordination with nuclear medicine centers 9. Additionally, patients must weigh the risk of long-term side effects, including urinary incontinence, erectile dysfunction, and systemic fatigue, emphasizing the need for comprehensive consultations with multidisciplinary experts.
Sources
- UCI Prostate Cancer Center, Newsweek and Statista America's Best Prostate Cancer Specialists Awards
- American Urological Association, Guidelines on Urologic Care and Specialist Selection
- The Doctor Directory, Specialty Database for Prostate Cancer Specialists
- Emory Healthcare, Dr. Martin G. Sanda Physician Profile and Academic Credentials
- Newsweek rankings, America's Best Hospitals for Specialized Care
- Definitive Healthcare Atlas, Hospital Volumes for Prostate Cancer Diagnoses
- Orlando Health College of Medicine, Clinical Research on Metastatic Prostate Cancer and Survival Rates
- Associated Urological Specialists, Biomarker Testing and Active Surveillance Research
- Medebound Health, Radioligand Therapy and Pluvicto Specialty Consultation Guide